619 related articles for article (PubMed ID: 36355199)
41. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
[TBL] [Abstract][Full Text] [Related]
42. Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort.
Boldrini L; Lenkowicz J; Orlandini LC; Yin G; Cusumano D; Chiloiro G; Dinapoli N; Peng Q; Casà C; Gambacorta MA; Valentini V; Lang J
Radiat Oncol; 2022 Apr; 17(1):78. PubMed ID: 35428267
[TBL] [Abstract][Full Text] [Related]
43. Hybrid model of CT-fractional flow reserve, pericoronary fat attenuation index and radiomics for predicting the progression of WMH: a dual-center pilot study.
Hou J; Jin H; Zhang Y; Xu Y; Cui F; Qin X; Han L; Yuan Z; Zheng G; Peng J; Shu Z; Gong X
Front Cardiovasc Med; 2023; 10():1282768. PubMed ID: 38179506
[TBL] [Abstract][Full Text] [Related]
44. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
Front Oncol; 2019; 9():552. PubMed ID: 31293979
[No Abstract] [Full Text] [Related]
45. Development and Validation of Contrast-Enhanced CT-Based Deep Transfer Learning and Combined Clinical-Radiomics Model to Discriminate Thymomas and Thymic Cysts: A Multicenter Study.
Yang Y; Cheng J; Peng Z; Yi L; Lin Z; He A; Jin M; Cui C; Liu Y; Zhong Q; Zuo M
Acad Radiol; 2024 Apr; 31(4):1615-1628. PubMed ID: 37949702
[TBL] [Abstract][Full Text] [Related]
46. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.
Yardimci AH; Kocak B; Sel I; Bulut H; Bektas CT; Cin M; Dursun N; Bektas H; Mermut O; Yardimci VH; Kilickesmez O
Jpn J Radiol; 2023 Jan; 41(1):71-82. PubMed ID: 35962933
[TBL] [Abstract][Full Text] [Related]
47. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
[TBL] [Abstract][Full Text] [Related]
48. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.
Shahzadi I; Zwanenburg A; Lattermann A; Linge A; Baldus C; Peeken JC; Combs SE; Diefenhardt M; Rödel C; Kirste S; Grosu AL; Baumann M; Krause M; Troost EGC; Löck S
Sci Rep; 2022 Jun; 12(1):10192. PubMed ID: 35715462
[TBL] [Abstract][Full Text] [Related]
49. The CT-based intratumoral and peritumoral machine learning radiomics analysis in predicting lymph node metastasis in rectal carcinoma.
Yuan H; Xu X; Tu S; Chen B; Wei Y; Ma Y
BMC Gastroenterol; 2022 Nov; 22(1):463. PubMed ID: 36384504
[TBL] [Abstract][Full Text] [Related]
50. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
[TBL] [Abstract][Full Text] [Related]
51. Machine Learning-based Analysis of Rectal Cancer MRI Radiomics for Prediction of Metachronous Liver Metastasis.
Liang M; Cai Z; Zhang H; Huang C; Meng Y; Zhao L; Li D; Ma X; Zhao X
Acad Radiol; 2019 Nov; 26(11):1495-1504. PubMed ID: 30711405
[TBL] [Abstract][Full Text] [Related]
52. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
[TBL] [Abstract][Full Text] [Related]
53. Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer.
Dinapoli N; Barbaro B; Gatta R; Chiloiro G; Casà C; Masciocchi C; Damiani A; Boldrini L; Gambacorta MA; Dezio M; Mattiucci GC; Balducci M; van Soest J; Dekker A; Lambin P; Fiorino C; Sini C; De Cobelli F; Di Muzio N; Gumina C; Passoni P; Manfredi R; Valentini V
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):765-774. PubMed ID: 29891200
[TBL] [Abstract][Full Text] [Related]
54. Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation.
Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Romano A; De Luca V; Votta C; Barbaro B; Gambacorta MA; Bassetti MF; Yang Y; Indovina L; Valentini V
Phys Med; 2021 Apr; 84():186-191. PubMed ID: 33901863
[TBL] [Abstract][Full Text] [Related]
55. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
[No Abstract] [Full Text] [Related]
56. Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study.
Liu X; Zhang D; Liu Z; Li Z; Xie P; Sun K; Wei W; Dai W; Tang Z; Ding Y; Cai G; Tong T; Meng X; Tian J
EBioMedicine; 2021 Jul; 69():103442. PubMed ID: 34157487
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer.
Cui Y; Liu H; Ren J; Du X; Xin L; Li D; Yang X; Wang D
Eur Radiol; 2020 Apr; 30(4):1948-1958. PubMed ID: 31942672
[TBL] [Abstract][Full Text] [Related]
58. Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
Liu Y; Zhang FJ; Zhao XX; Yang Y; Liang CY; Feng LL; Wan XB; Ding Y; Zhang YW
Cancer Manag Res; 2021; 13():3235-3246. PubMed ID: 33880066
[TBL] [Abstract][Full Text] [Related]
59. Multi-task reconstruction network for synthetic diffusion kurtosis imaging: Predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Ma Q; Liu Z; Zhang J; Fu C; Li R; Sun Y; Tong T; Gu Y
Eur J Radiol; 2024 May; 174():111402. PubMed ID: 38461737
[TBL] [Abstract][Full Text] [Related]
60. Attention mechanism based multi-sequence MRI fusion improves prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Zhou X; Yu Y; Feng Y; Ding G; Liu P; Liu L; Ren W; Zhu Y; Cao W
Radiat Oncol; 2023 Oct; 18(1):175. PubMed ID: 37891611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]